When adults with Parkinson’s sing in a group, their stress levels (measured by a chemical in saliva) seem to drop after the second time they sing—but not every time—so singing might sometimes calm their nervous system, but not always.

A randomized controlled trial with 8+ adults with Parkinson’s disease, each participating in multiple group singing sessions (e.g., 4–6 sessions), with salivary alpha amylase measured before and after each session, and a control condition (e.g., quiet rest) matched for time and social interaction, to determine if reduction occurs specifically after session two and varies across sessions.

A prospective study tracking 8+ adults with Parkinson’s disease over multiple weekly group singing sessions, measuring salivary alpha amylase before and after each session, to observe whether a significant drop occurs consistently after session two and whether the effect varies across sessions without randomization.

A small pilot study measuring salivary alpha amylase before and after each of 3–6 group singing sessions in 8 adults with Parkinson’s to document whether a pattern of reduction emerges specifically after session two, with variability noted across sessions.

A case series reporting salivary alpha amylase changes across sessions in a small group of adults with Parkinson’s who participated in group singing, documenting whether session two consistently showed reduction and whether effects were variable.

A qualitative study exploring participants’ experiences during group singing alongside salivary alpha amylase measurements to understand why effects might vary across sessions, particularly after session two.